NCT03022695已完成不适用
Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 27
- 试验地点
- 2
- 主要终点
- The efficacy is assessed by a reduction in volume of the fibroadenoma at baseline, 6 months and at 12 months after the HIFU on the ultrasonography.
研究概览
简要总结
This is a monocenter, open-label, uncontrolled study in accordance with §23b MPG to evaluate the efficacy of the HIFU-treatment of fibroadenoma using the TH-One device.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Female patients 18 years or older with at least one diagnosed breast fibroadenoma. Diagnosis of fibroadenoma must be based on:
- •clinical examination,
- •women ≤ 40 years of age: ultrasound image alone; women > 40 years of age: ultrasound image and mammogram,
- •histological confirmation of fibroadenoma of the breast. Patient's fibroadenoma size as determined by ultrasound imaging: the longest diameter is limited to 25 mm. Women of childbearing potential must have a negative urine pregnancy test within 72 hours prior to HIFU treatment. Patient must be able to understand the nature and the extent of the study and the procedures required and be willing and able to complete the screening and study procedures. Patient must give written informed consent (personally signed and dated) before completing any study-related procedure.
排除标准
- •Patient who is pregnant or breast-feeding.
- •Patient with history of ipsilateral breast cancer within 5 years prior to study inclusion or radio therapy to the target breast within 5 years prior to study inclusion.
- •Patient with implant on the treated breast.
- •Patient with target fibroadenoma pre-treated by cryoablation or interstitial laser therapy within 12 month before recruiting for HIFU.
- •Patient's fibroadenoma not clearly visible on the ultrasound images (in B mode) at the inclusion visit. Patient participating in other studies using drugs or medical devices within 3 months prior to study inclusion or during study participation including the follow-up period.
结局指标
主要结局
The efficacy is assessed by a reduction in volume of the fibroadenoma at baseline, 6 months and at 12 months after the HIFU on the ultrasonography.
时间窗: Baseline, 6 months, 12 months
A reduction in volume of \> 65% compared to baseline, or a total regression of the fibroadenoma will be taken as effective treatment. The results will be analyzed descriptively
次要结局
- Pain during the HIFU session using a Visual Analog Pain Scale(0 month)
- Histological outcome through core needle biopsy after 12 month(1 year)
- Energy setting to obtain reduction in volume or total regression of the fibroadenoma at 12 months follow-up(1 year)
- Lack of palpable lesion(2 years)
- Pain free if pain at baseline (pain related to the fibroadenoma)(1 year)
- Gland vascularisation (compared to baseline) power Doppler at day 7, month 6 and 12 after the HIFU session(Day 7, month 6, month 12)
- Quality and ease of use of breast immobilization(1 year)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)Breast FibroadenomaNCT02011919Theraclion27
终止
不适用
Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)Breast FibroadenomaNCT03742401Theraclion2
Unknown
不适用
Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)Breast FibroadenomaNCT01331954Theraclion20
已完成
不适用
Treatment of Breast Fibroadenoma With High Intensity Focused UltrasoundBreast FibroadenomaNCT02078011David R. Brenin, MD20
已完成
不适用
Treatment of Breast Fibroadenoma Targeted Tissue With HIFUBreast FibroadenomaNCT03044054Theraclion113